CO2 Laser (Carbon Dioxide Fractional / Ablative Laser Resurfacing)
CO2 laser resurfacing is a private aesthetic-clinic procedure that uses a laser to remove the very top layers of skin in a controlled way, triggering the skin to heal and rebuild itself smoother. It is used for fine lines, uneven texture, sun damage, and acne scars. It is NOT an NHS service for cosmetic concerns (though NHS dermatology uses CO2 lasers for some clinical skin conditions). Camden Medicals does NOT provide this procedure. Two things to know if you're researching: (1) it is one of the more aggressive aesthetic treatments — expect 5-10 days of visible redness and crusting after each session, plus SPF 50+ for several months while skin heals; (2) the UK has clear safety frameworks for who can do it — clinics offering it must be CQC-registered, and practitioners should be on the JCCP or Save Face register. Check before you book. Pregnancy and breastfeeding: not recommended. The UK British Association of Dermatologists advises postponing all elective aesthetic procedures until after delivery and breastfeeding.
Camden Medicals editorial · Last reviewed 6 May 2026 · Next review May 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Other
- Typical daily dose
- Fluence + pulse parameters set by practitioner; 2-4 sessions over 3-6 months typical for fractional CO2 photoaging protocols.
- Top use evidence
- Strong
On this page
What it is
The CO2 laser is one of several lasers used in cosmetic clinics for skin resurfacing. It works by sending a precise beam of light at a wavelength that water in skin absorbs strongly — turning the top layer of skin into vapour in a controlled, measured way. The skin then heals over the next 5-10 days, and as part of that healing process it lays down new collagen and reorganises its surface, leaving smoother texture and softer fine lines.
There are two ways CO2 lasers are used today:
Fractional CO2 (the modern standard) — the laser works on the skin in a grid of tiny columns, leaving healthy skin in between. The untreated bridges between columns heal the treated zones faster. Downtime is 5-10 days; results emerge over 3-6 months; typically 2-4 sessions for best results.
Fully-ablative CO2 (the 1990s approach, less common now) — the laser covers the whole surface in one go. Stronger per-session result, but 2-3 weeks of downtime and a higher complication rate. Reserved for specific contexts now that fractional is available.
Camden Medicals does NOT provide CO2 laser. The UK pathway if you want to research it:
1. Check the clinic is on the CQC register (for surgical-tier procedures in England; equivalent registers in Scotland, Wales, Northern Ireland).
2. Check the practitioner is on the JCCP register or Save Face register.
3. Have a consultation FIRST — the consultation should ask about your medication history (especially isotretinoin), pregnancy plans, skin type, history of cold sores, and current skincare routine.
4. Avoid promotional discounts that bypass the consultation step — this is a red flag.
At a glance
- Private aesthetic-clinic procedure. NOT NHS-funded for cosmetic concerns. Camden does NOT provide.
- 5-10 days of visible redness + crusting after each session. SPF 50+ for ≥3 months while skin heals.
- Multiple sessions (2-4) typical. Results emerge over 3-6 months.
- CHECK before booking: clinic on the CQC register (for surgical-tier), practitioner on JCCP or Save Face.
- NOT recommended in pregnancy or breastfeeding. Talk to your midwife or GP.
- AVOID for ≥6 months after stopping isotretinoin — wound healing is impaired and scarring risk rises.
- Higher complication risk on darker skin tones (post-inflammatory hyperpigmentation) — choose a practitioner experienced with your skin type.
What people use it for
Adults considering aesthetic CO2 laser for moderate-to-severe photoaging
Modern fractional CO2 produces measurable improvements in fine lines, texture, dyspigmentation over 3-6 months with 5-10 days downtime per session. Multiple sessions (2-4) typical for equivalent effect to single fully-ablative session. UK aesthetic-medicine pathway: CQC-registered clinic, JCCP-registered practitioner. Camden does NOT provide; private clinic referral. [1]
Some evidenceModerateAdults with atrophic acne scars
CO2 fractional has trial evidence for atrophic acne scar appearance reduction (multiple sessions, 3-6 months recovery). UK NICE NG198 acne pathway addresses active acne; scar revision is a separate aesthetic-medicine context. Combined with subcision + filler in some clinical protocols. [2]
Some evidenceLimitedPregnant or breastfeeding women
AVOID elective aesthetic CO2 laser. UK BAD / RCOG Aesthetic Procedures in Pregnancy guidance: defer non-essential aesthetic procedures until after delivery + breastfeeding. Topical anaesthetics + post-procedure analgesia raise additional considerations. [9]
Some evidenceStrongAdults with Fitzpatrick IV-VI skin types
Higher complication risk (post-inflammatory hyperpigmentation, hypopigmentation, scarring) in darker skin tones. Choose practitioner experienced in darker skin tones; non-ablative alternatives (Erbium 1550 nm fractional, picosecond, RF microneedling) may be lower-risk.
Some evidenceLimitedAdults on isotretinoin (Roaccutane / Reticutan)
Fully ablative CO2 laser is not recommended during a course of oral isotretinoin (2017 systematic-review consensus, Spring et al., JAMA Dermatol). For the period after stopping, that consensus found insufficient evidence to support the traditional ≥6-month delay — the old rule rested on three small 1980s case series — and fractional resurfacing was not found to require a delay. Discuss timing with your prescriber. [10]
Some evidenceLimited
How it works
When laser energy lands on skin, water absorbs the energy and instantly turns to vapour — taking the top layer of skin with it. The cells just below the treatment zone are heated but not destroyed, and this controlled heat triggers a wound-healing response: the skin closes over, fibroblasts (the cells that build connective tissue) ramp up collagen production, and over weeks to months the dermis remodels into a more organised, firmer structure.
The reason fractional CO2 has replaced the older fully-ablative approach for most cosmetic work is the speed of healing. With fractional, only a fraction of the surface is treated in each session — the untreated grid in between contains all the live skin cells the body needs to heal the treated columns. This dramatically reduces downtime and complications compared to treating the whole surface at once.
The procedure is most effective for fine lines, sun damage, and atrophic acne scars (the indented kind), where rebuilding the dermal scaffolding is the right intervention. It is less effective for deep wrinkles or sagging — those have more to do with underlying tissue support than skin surface, and a different procedure (RF microneedling, ultrasound tightening, surgical lift) may be a better match. A good consultation tells you which one is right for your concern.
Common myths
Myth""CO2 laser is the same as IPL or non-ablative laser.""
RealityDifferent technologies. CO2 ablates tissue (10,600 nm, water absorption); IPL is broadband non-coherent light (500-1200 nm, multiple chromophores); non-ablative laser (Fraxel, picosecond) operates without surface ablation. Different downtime, different aesthetic outcomes, different risk profiles.
Myth""You can do CO2 laser during pregnancy as long as you do not use anaesthetic.""
RealityUK BAD / RCOG guidance: defer non-essential aesthetic procedures until after delivery + breastfeeding. Even without topical anaesthetic, the wound-healing cascade and post-procedure analgesia raise concerns.
Myth""CO2 laser is permanent.""
RealityAesthetic outcomes from CO2 laser persist for years but skin continues to age via UV exposure + intrinsic processes. Maintenance treatments + sunscreen + topical retinoid + lifestyle modifiers maintain results.
What people say online
CO2 laser is a high-volume search cluster on TikTok and r/SkincareAddiction. The dominant narrative is recovery-journey content ("day 5 post fractional CO2") which compresses the genuine 5-10 day downtime into watchable timelapses, plus comparison content ("CO2 vs Erbium" / "CO2 vs Morpheus8"). UK consumers are particularly poorly served by US-clinic-centred content because the UK regulatory pathway (CQC / JCCP / Save Face) is materially different from the US dermatology / cosmetic-surgery delivery model. This section surfaces the discourse without naming individual influencers and refers each claim to UK authority.
Trending claims
- TikTokhigh visibility
Claim: Fractional CO2 = a few days downtime maximum
Reality check: Modern fractional CO2 has 5-10 day downtime (erythema + crusting + mild swelling for 3-7 days; residual pinkness 1-3 weeks). Timelapse content compressing 5-10 days into a 15-second video misrepresents the practical disruption. UK consumers should plan time off work / events.
- Reddit (r/SkincareAddiction)high visibility
Claim: CO2 laser fixes acne scars in one session
Reality check: Multiple sessions (2-4) are typical for fractional CO2 at atrophic-scar protocols, with results emerging over 3-6 months. Single-session results are visible but modest; full aesthetic outcome is cumulative. UK NICE NG198 covers active-acne pathway only; scar revision is a separate aesthetic-medicine context outside NHS provision. [2]
- TikTok (Fitzpatrick IV-VI content)medium visibility
Claim: CO2 laser works on dark skin if you use the right settings
Reality check: Higher post-inflammatory hyperpigmentation risk in Fitzpatrick IV-VI skin types is well-documented (Luo 2012, PMID 23135080). Practitioner experience with darker skin tones is the load-bearing safety mechanism, not settings adjustment alone. Non-ablative alternatives (Erbium 1550 nm fractional, picosecond, RF microneedling) may be lower-risk options for darker skin tones. [7]
- TikTok + Instagram (promotional posts)medium visibility
Claim: Skip the consultation — go straight to the deal
Reality check: Pre-procedure consultation is the load-bearing safety mechanism. Isotretinoin history (≥6 months wash-out required), retinoid pause (7-14 days), Fitzpatrick skin type assessment, herpes simplex history (HSV prophylaxis consideration), pregnancy status — all should be checked before fluence parameters are set. Promotional discounts that bypass consultation are a red flag, not a deal.
Where the conversation lives
- TikTok hashtags: #fractionalco2, #co2laser, #co2recovery, #lasersurfacing
- Reddit subs: r/SkincareAddiction, r/30PlusSkinCare, r/Skincare_Addiction_UK
- Forums: RealSelf (US-centric, US-clinic discussions dominate), MumsNet (UK clinic recommendations)
Questions people are searching
- How bad is the downtime really?
- CO2 vs Morpheus8 — which is better?
- Can I get CO2 laser on dark skin?
- How many sessions do I actually need?
- Is the NHS going to do CO2 laser?
Who drives the discourse: The discourse is driven by three influencer classes: aesthetic- medicine doctor creators (most evidence-anchored on UK CQC / JCCP context); patient recovery-vlogger creators (highest reach but inconsistent on UK regulatory framing); and clinic-affiliated creators (sometimes-undeclared commercial relationships). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about CO2 Laser (Carbon Dioxide Fractional / Ablative Laser Resurfacing). Each answer is editorial and links to its evidence in the Sources list below.
How long is downtime after fractional CO2 laser?
5-10 days typical: erythema + crusting + mild swelling for 3-7 days; residual pinkness for 1-3 weeks. Plan time off work / events. Fully-ablative CO2 has longer downtime (2-3 weeks) and is less commonly used now.
Should I stop my retinol before CO2 laser?
Yes — stop topical retinoids (retinol / retinal / tretinoin / adapalene / tazarotene) 7-14 days before procedure. Resume topical retinoid ≥4-6 weeks post-procedure when re-epithelialisation is complete and barrier function restored.
Can I do CO2 laser if I am on isotretinoin?
No — contraindicated during oral isotretinoin course + ≥6 months after. Impaired wound healing risk + documented hypertrophic scarring. Wait ≥6 months after stopping isotretinoin before any ablative laser.
How do I find a UK CO2 laser practitioner?
Look for: CQC registration (clinic level); JCCP or Save Face practitioner registration (individual level); GMC/GDC registration if doctor/dentist provider. Avoid practitioners without verifiable training. Camden does NOT provide aesthetic CO2 laser. [1]
UK regulatory landscape
UK regulatory tier: Medical device
The CO2 laser device itself is a Class IIb medical device under the UK Medical Devices Regulations 2002 (as amended) and the assimilated EU MDR 2017/745. The aesthetic-medicine PROVIDER is subject to CQC registration when delivering surgical-tier procedures in England (with equivalent frameworks in Scotland via Healthcare Improvement Scotland, in Wales via Healthcare Inspectorate Wales, and in Northern Ireland via RQIA). The INDIVIDUAL practitioner is subject to professional-register requirements via the JCCP (Joint Council for Cosmetic Practitioners) and Save Face. NHS does NOT provide CO2 laser for aesthetic indications; private aesthetic-medicine clinics are the consumer pathway. Clinical indications (actinic keratosis, scar revision in selected contexts) may be delivered in NHS dermatology.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing language implies treatment of a medical condition (active acne, eczema, rosacea, skin cancer) | Crosses to medicinal-treatment / MHRA Borderline classification; aesthetic-clinic marketing under those framings is non-compliant. |
| Provider lacks CQC registration but delivers surgical-tier procedures in England | CQC enforcement; provider may be required to cease operating until registered. |
| Device is used at parameters beyond its MHRA-authorised intended-use indication | Off-label use is at practitioner clinical-judgement risk; outside the device-manufacturer evidence base and product-liability protection. |
Permitted claims
Aesthetic-procedure marketing claims must be substantiated + truthful + decent + honest under the UK ASA / CAP Code (with ASA CAP Code §12 on medicines, medical devices, health-related products and beauty products). Permitted: descriptive procedure claims, demonstrable cosmetic benefits supported by trial evidence, transparent disclosure of CQC / JCCP / Save Face registration. NOT permitted: medical-condition treatment claims without licensing, "permanent" or "cure" framing, before / after images that exceed the average trial-evidence effect size.
Cross-jurisdiction note
US aesthetic-medicine regulation (FDA Class II / Class III device pathway + state cosmetic-surgery licensure) differs from the UK framework. US-clinic-centred TikTok content does NOT translate one-to-one — UK consumers should not assume the US delivery model applies in their local clinic context.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Photoaging — fine lines, texture, dyspigmentation
ModerateEvidencemoderateMultiple RCTs and cohort studies support fractional CO2 for photoaging with 3-6 month results. [1,11,12,13,14,15,16]
Atrophic acne scars
LimitedEvidencelimitedTrial evidence supports fractional CO2 for atrophic acne scar appearance reduction, but GRADE certainty is low — small, operator-dependent split-face trials and no large multicentre RCTs. [2]
Actinic keratoses
LimitedEvidencelimitedCO2 laser is one of multiple ablative options for actinic keratoses in UK NHS dermatology context.
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| Facial wrinkles and fine lines (photoaging) | adults | — | 12–24 wk | ModerateEvidencemoderate | improvement | PMID 17311274 PMID 20120420 PMID 20166156 PMID 23110481 PMID 20384754 |
| Procedure dose: 2-4 sessions over 3-6 months at fractional pulse-energy parameters set by practitioner. Hantash 2007 foundational mechanism paper documents HSP47-driven collagen remodelling persisting at 3 months. Trial body is small-sample / single-centre; effect direction consistent across 20 years of evidence. Convention B1 — sessions field will land once A1 enum extension ships. | ||||||
| Atrophic acne scars | adults | — | 12–24 wk | LimitedEvidencelimited | improvement | PMID 17311274 |
| Procedure dose: 2-4 sessions over 3-6 months at atrophic-scar protocols (deeper fluence than photoaging). UK NICE NG198 covers active-acne pathway only — scar revision is separate aesthetic-medicine context outside NHS provision. Effect cumulative over 3-6 months; single-session results modest. | ||||||
| Photoaging (texture and dyspigmentation, Fitzpatrick II-III) | adults | — | 12–24 wk | ModerateEvidencemoderate | improvement | PMID 31957958 PMID 34889041 PMID 21605239 |
| Procedure dose: 2-4 sessions over 3-6 months. Nelson & Ortiz 2020 (n=5 split-face) documents post-procedure peptide-adjunct recovery acceleration; supports the cluster pattern of recovery adjuncts. Population restricted to Fitzpatrick II-III where PIH risk is lower — see Row 4 for Fitzpatrick IV-VI caveat. Population enum needs Fitzpatrick tiers (see SCHEMA-EXTENSION-REQUESTS.md §A3). | ||||||
| Post-inflammatory hyperpigmentation (PIH adverse-event) | adults | — | 12–24 wk | ModerateEvidencemoderate | decrement | PMID 23135080 PMID 36943760 |
| LOAD-BEARING CAVEAT row. Luo 2012 split-face RCT (n=18 Fitzpatrick IV Chinese subjects): UPCO2 mode had higher incidence of oedema, spot bleeding, prolonged redness, and PIH vs SPCO2. Fitzpatrick IV-VI consumers face materially higher PIH adverse-event risk than Fitzpatrick I-III. Practitioner-experience and parameter selection are load-bearing. Camden does NOT provide CO2 laser; UK CQC/JCCP/Save Face framework applies. Population enum needs Fitzpatrick tiers. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
The fractional CO2 laser literature spans roughly two decades. Hantash et al. 2007 (Lasers Surg Med, PMID 17311274) characterised the ablative-fractional resurfacing mechanism histologically — the device deposits an array of microscopic treatment zones (MTZ) of ablation surrounded by columns of thermal coagulation, with heat-shock protein 47 expression persisting at 3 months indicating sustained collagen-remodelling response. Subsequent split-face and single-arm trials have refined the dose-response (pulse energy 5-40 mJ → 3-fold lesion depth increase) and characterised adverse-event profiles in Fitzpatrick III-VI skin (Luo et al. 2012, PMID 23135080: SPCO2 preferred over UPCO2 in Fitzpatrick IV for fewer adverse effects with similar efficacy). Recent RCTs have focused on post-procedure adjuncts to accelerate recovery (Nelson & Ortiz 2020, PMID 31957958: TriHex peptide gel reduces redness + roughness post hybrid fractional laser). The structural weakness of the evidence body is small sample sizes (typical n=5-20 split-face protocols) and dominance of single-centre case series; large multicentre RCTs remain rare.
Key trials
Hantash BM et al. · 2007 · Lasers Surg Med · PMID 17311274
Finding: Foundational in-vivo histological evaluation of a novel ablative fractional CO2 laser (30 W, 10.6 µm, 120 µm spot size). 5-40 mJ pulse energy produced microscopic treatment zones of ablation surrounded by thermal coagulation columns spanning epidermis + part of dermis. Heat-shock protein 47 expression first detected at 7 days and persisted at 3 months — indicates sustained collagen-remodelling response.
Relevance: Foundational paper for the fractional CO2 mechanism. All subsequent fractional CO2 platforms (Lumenis Acupulse, Sciton Profractional, DEKA SmartXide) build on the microscopic-treatment-zone pattern characterised here.
Luo YJ et al. · 2012 · J Drugs Dermatol · PMID 23135080
Finding: Split-face comparison of ultrapulse-mode (UPCO2) and superpulse-mode (SPCO2) fractional CO2 in Fitzpatrick IV Chinese subjects. Similar efficacy on photoaged-skin markers at 1 and 3 months. SPCO2 had less erythema and more crusting; UPCO2 had higher incidence of oedema, spot bleeding, prolonged redness, and post-inflammatory hyperpigmentation. More subjects preferred SPCO2.
Relevance: Direct evidence on darker-skin (Fitzpatrick IV) treatment tolerability — confirms higher PIH risk in darker skin tones and supports the practitioner-experience importance for Fitzpatrick IV-VI consumers.
Choi SM et al. · 2023 · J Cosmet Dermatol · PMID 36943760
Finding: Single-session fractional CO2 laser resurfacing in 15 Asian subjects (14 completed) with facial skin aging, followed by post-procedure application of human dermal fibroblast-derived extracellular matrix (ECM) vs placebo, split-face. Melanin level — the post-inflammatory hyperpigmentation marker — was significantly LOWER on the ECM side than the placebo (plain post-CO2) side at week 12 (p < 0.05), and erythema increase at week 4 was greater on the control side. The plain fractional CO2 side therefore produced measurable PIH that the adjunct mitigated.
Relevance: Second darker-skin (Asian) split-face RCT documenting post- inflammatory hyperpigmentation after fractional CO2 resurfacing (alongside Luo 2012). Grounds the effect_matrix PIH adverse- event row's second citation and corroborates elevated PIH risk in Fitzpatrick III-V skin treated with fractional CO2.
Nelson AM, Ortiz AE · 2020 · J Cosmet Dermatol · PMID 31957958
Finding: Anhydrous gel with TriHex tripeptide / hexapeptide blend reduced post-procedure redness (days 1, 4) and roughness (days 3, 4) on the peptide-treated side vs standard regimen after hybrid fractional laser resurfacing. 4 of 5 subjects preferred the peptide regimen.
Relevance: Mechanism-cluster evidence: post-CO2 fibroblast-signal peptide adjuncts accelerate the wound-healing-cascade recovery phase. Small sample size; supports the post- procedure recovery adjunct pattern at the cluster level rather than as definitive product evidence.
Evidence quality summary
The fractional CO2 evidence base is mechanism-clear + clinical- modest at trial-rigour standards. Most RCTs are small (n<30) and single-centre. The mechanism-of-action is well-characterised (Hantash 2007 histology, sustained HSP47 expression). The cosmetic-outcome trials consistently show modest improvements in fine lines, texture, and dyspigmentation at 3-6 months. The adverse-event profile is well-documented and higher in Fitzpatrick IV-VI skin types (Luo 2012). GRADE-style: MODERATE certainty for moderate photoaging improvement at standard protocols in Fitzpatrick II-III skin; LOW certainty for Fitzpatrick IV-VI; LOW certainty for atrophic-scar revision magnitude vs alternative modalities.
Known gaps
- No large multicentre RCTs comparing fractional CO2 vs Erbium fractional vs RF microneedling head-to-head.
- No long-term (>5 year) follow-up trials.
- Limited UK-specific outcome data — most trials are US / Asian / European cosmetic-clinic populations.
- No paediatric or pregnancy-specific safety data (procedure is contraindicated in those contexts).
- Practitioner-experience variable not captured systematically in published evidence — outcomes are strongly operator-dependent.
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
CO2 laser is an aggressive aesthetic intervention with substantial downtime + complication risk profile. UK CQC / JCCP / Save Face regulatory framework. Camden does NOT provide.
Talk to your pharmacist or GP first if you:
- You are pregnant, breastfeeding, or trying to conceive — defer.
- You are on isotretinoin or within 6 months of stopping — contraindicated.
- You take immunosuppressants — wound-healing concern.
- You have active acne, rosacea flare, or eczema flare — defer.
- You have a history of keloid or hypertrophic scarring — high-risk.
- You are Fitzpatrick IV-VI — choose practitioner with darker-skin experience.
- You take photosensitising medication (doxycycline, amiodarone, hydrochlorothiazide) — increased post-procedure photosensitivity.
Common side effects: Erythema, swelling, crusting, mild discomfort 3-10 days. Post-inflammatory hyperpigmentation in darker skin types. Rare: scarring, persistent erythema, infection.
Pregnancy and breastfeeding
Elective aesthetic CO2 laser is not recommended in pregnancy. UK BAD / RCOG aesthetic-procedures-in-pregnancy guidance is to defer non-essential procedures until after delivery and breastfeeding. Topical anaesthetics + post-procedure analgesia raise additional considerations. Talk to your midwife or GP if you are uncertain.
Elective aesthetic CO2 laser is not recommended during breastfeeding for the same defer-to-after-feeding rationale — topical anaesthetic absorption, post-procedure analgesia, and infection-prevention considerations all benefit from deferral. Talk to your midwife or GP.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Pregnancy and breastfeeding (UK BAD / RCOG).
- Concurrent oral isotretinoin or within 6 months of stopping.
- Concurrent immunosuppressants.
- Active acne, rosacea, or eczema flare in the treatment area.
- History of keloid or hypertrophic scarring.
- Active herpes simplex outbreak (relative; antiviral prophylaxis option).
- Photosensitising medication.
- Hypersensitivity to lidocaine / topical anaesthetics.
Drug interactions
Oral isotretinoin (Roaccutane, Reticutan, generics) · high
Effect: Impaired sebaceous + adnexal function delays wound healing post-CO2 ablation; documented hypertrophic-scarring risk. CONTRAINDICATION-LEVEL during the entire isotretinoin course and for ≥6 months after stopping.
Mechanism: Systemic 13-cis-retinoic acid suppresses sebocyte function + adnexal-stem-cell wound-healing capacity. Ablative laser relies on intact appendageal structures for re-epithelialisation; compromise produces hypertrophic + atrophic scarring.
Action: Tell your dermatologist if you have taken oral isotretinoin in the last 6-12 months; the procedure should be deferred until the wash-out is documented.
Source: BAD / NICE NG198 + Camden isotretinoin entry
Topical retinoids (tretinoin, adapalene, tazarotene, retinol, retinal) · medium
Effect: Pre-procedure pause required (7-14 days) to allow stratum corneum normalisation; post-procedure delay (≥4-6 weeks) to allow re-epithelialisation + barrier rebuild before resuming.
Mechanism: Active retinoid signalling thins stratum corneum + accelerates cell turnover — increases procedural irritation + delays recovery if not paused.
Action: Tell your dermatologist or aesthetic-medicine practitioner about any topical retinoid use; they will set the pause + resume timeline based on the specific molecule and concentration.
Source: Camden retinol entry + clinic protocols
Photosensitising medications (doxycycline, amiodarone, hydrochlorothiazide, certain diuretics) · medium
Effect: Increased post-procedure photosensitivity — SPF 50+ for ≥3 months is the universal recommendation; photosensitising medications make this even more critical.
Mechanism: Drug-induced photosensitivity reactions amplify UV-damage risk during the post-procedure healing window when barrier function is compromised.
Action: Tell your prescriber and the aesthetic-medicine practitioner about any long-term photosensitising medication. Procedure scheduling and post-procedure SPF discipline both adjust.
Source: BNF photosensitivity drug list
Anticoagulants (warfarin, DOACs) · low
Effect: Modest bleeding-risk consideration during fractional ablation; not an absolute contraindication but warrants prescriber + practitioner coordination.
Mechanism: Fractional ablation produces pinpoint bleeding from ablation zones; coagulation status affects the bleeding magnitude + recovery profile.
Action: Tell your anticoagulation clinic and the aesthetic-medicine practitioner. Do not adjust anticoagulant dose without prescriber instruction.
Source: BNF anticoagulation
Systemic immunosuppressants (post-transplant regimens, biologics) · high
Effect: Impaired wound healing and infection risk; procedure typically deferred during active immunosuppression.
Mechanism: Impaired neutrophil + fibroblast function delays the wound- healing cascade that drives both recovery and the cosmetic outcome.
Action: Talk to the prescribing team (transplant unit / rheumatology / dermatology) before any aesthetic CO2 procedure.
Source: BNF immunosuppression
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Erythema, swelling, crusting 3-10 days.
- Itching during re-epithelialisation.
- Mild post-procedure discomfort.
Rare side effects
- Post-inflammatory hyperpigmentation (higher risk in Fitzpatrick IV-VI).
- Hypopigmentation (rare).
- Scarring (rare).
- Persistent erythema (rare; weeks to months).
- Bacterial / viral infection (HSV reactivation; antiviral prophylaxis sometimes used).
- Hypertrophic scarring (rare; higher in isotretinoin / immunosuppressant context).
How to take it
- Typical supplemental range
- Fluence + pulse parameters set by practitioner; 2-4 sessions over 3-6 months typical for fractional CO2 photoaging protocols.
- Timing
- Procedure-based; not a dose context.
How to spot quality
Look for
- CQC registration of clinic.
- JCCP or Save Face practitioner registration.
- GMC / GDC registration if medical / dental provider.
- Patch test for darker Fitzpatrick skin types.
- Pre-procedure consultation including topical-retinoid pause + isotretinoin history.
- Post-procedure care protocol including SPF 50+ requirement.
Red flags
- No CQC / JCCP / Save Face registration.
- Provider without verifiable training.
- No patch test in darker Fitzpatrick skin types.
- No isotretinoin / pregnancy history check.
- No post-procedure SPF guidance.
- Promotional discounts that bypass consultation requirements.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Microneedling (Collagen Induction Therapy / Percutaneous Collagen Induction)
Limited evidenceAesthetic-procedure cluster — sometimes combined or sequenced (microneedling first, CO2 several months later) for cumulative remodelling.
Microneedling mechanical micro-channels + collagen induction; CO2 thermal ablation + collagen remodelling. Different mechanisms targeting overlapping outcomes. Sequenced clinical protocols use microneedling for maintenance between CO2 sessions.
Evidence: Combination protocols at clinician discretion.
Doses studied: Practitioner-determined sequencing.
Radiofrequency Skin Tightening (RF Skin Therapy / Subdermal RF Heating)
Limited evidenceAesthetic-procedure cluster — RF and CO2 target overlapping outcomes through different energy modalities.
CO2 laser ablation + collagen remodelling; RF non-ablative dermal heating + collagen contraction. Different mechanisms. Some clinical protocols sequence both for cumulative effect.
Evidence: Combination at clinician discretion.
Doses studied: Practitioner-determined.
Vitamin C topical (L-ascorbic acid + ester derivatives)
Limited evidencePost-procedure recovery adjunct — vitamin C antioxidant + procollagen-cofactor compatible during re-epithelialisation.
Vitamin C antioxidant ROS scavenging + procollagen hydroxylation cofactor. Compatible with post-CO2 wound-healing cascade. Use only after re-epithelialisation complete (typically week 1-2). Pair with sunscreen.
Evidence: Compatible adjunct.
Doses studied: Post-CO2 day 7-14: 10-20% L-ascorbic acid AM + sunscreen.
Niacinamide (Topical, Vitamin B3 amide form)
Limited evidencePost-procedure barrier-rebuild adjunct.
Niacinamide ceramide / FFA synthesis support compatible with post-CO2 barrier rebuild. Use only after re-epithelialisation complete.
Evidence: Compatible adjunct.
Doses studied: Post-CO2 day 7-14: 5% niacinamide AM + PM.
Polypeptides (Cosmetic peptides — signal / carrier / neurotransmitter-inhibiting)
Limited evidencePost-procedure fibroblast-signal adjunct.
Cosmetic peptides (Matrixyl, GHK-Cu) provide direct fibroblast signal; CO2 thermal damage triggers fibroblast wound-healing cascade. Mechanism complementary on collagen-remodelling axis. Use after re-epithelialisation complete.
Evidence: Compatible adjunct.
Doses studied: Post-CO2 day 14+: peptide serum PM.
Verifera™ editorial perspective
Why it matters. CO2 laser resurfacing is one of the most-searched aesthetic procedures in the UK, with consumer-research patterns split between "fractional CO2" enquiry on TikTok and "CO2 vs Erbium vs RF microneedling" comparison on Reddit. The Verifera editorial position is that this entry should be a careful UK- regulatory-anchored reference for consumers researching the aesthetic-medicine procedure cluster — and that the framing must be unmistakable: this is a Class IIb medical device delivered in CQC-registered clinics by JCCP / Save Face practitioners, NOT a supplement Camden retails.
Where Camden lands. Camden Medicals does NOT provide CO2 laser resurfacing. Camden retails oral food-supplement and topical-cosmetic ingredients only; aesthetic-procedure delivery is outside Camden's regulatory scope. We declare this commercial transparency clearly.
If you want to explore further. For UK consumers researching the procedure: the NHS cosmetic- procedures page is the starting reference; the CQC register lists clinics with surgical-tier registration; the JCCP and Save Face registers list trained practitioners. For a specific clinical concern (severe photoaging, atrophic acne scarring), the appropriate pathway is GP referral to dermatology.
How this entry was researched
Authoritative sources consulted:
- NHS cosmetic-procedures + acne pages
- NICE NG198 acne vulgaris guideline
- UK MDR 2002 (Medical Devices Regulations) + EU MDR 2017/745
- CQC register of cosmetic clinics (England)
- JCCP register of cosmetic practitioners
- Save Face register of accredited practitioners
- BAD (British Association of Dermatologists) consensus statements
- PubMed (via E-utilities MCP)
PubMed search terms:
Hantash fractional CO2 ablative laser histologicalfractional carbon dioxide laser photoaging randomized controlled trialCO2 laser Fitzpatrick darker skin post inflammatory hyperpigmentationpost laser peptide wound healing
Literature search date: 2026-05-11
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.